TCRX is trading at $0.85, down 10.8% versus the comparison close of $0.95 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
π΄ Tscan Therapeutics Inc makes sharp 10.8% drop
Tscan Therapeutics Inc
Related News
TCRX
TScan's Blood Cancer Therapy Shows Early Promise, but Can a Sub-Dollar Stock Survive Long Enough to Prove It?
TCRX
π’ TCRX is trading 9% up today on positive Phase 1 data for TSC-101
TCRX
TScan Announces Positive Phase 1 Data for TSC-101 in Heme Malignancies
TCRX
π’ Tscan Therapeutics Inc is trading 5.2% up today after presenting positive data from its ALLOHAβ’ Phase 1 study
TCRX